Glucophage Xr

Glucophage XR is an oral extended‑release tablet that contains the active ingredient metformin hydrochloride. It is marketed in the European Union and is available in several tablet strengths. As a biguanide antidiabetic medication, Glucophage XR is prescribed to help manage blood glucose levels in adults with type 2 diabetes mellitus, offering a once‑daily dosing option.

Glucophage XR is indicated for the management of type 2 diabetes mellitus as part of a comprehensive treatment plan that includes diet and exercise.

- Improves glycemic control in adults with type 2 diabetes. - Used as monotherapy when diet and exercise alone are insufficient. - Can be combined with other oral antidiabetic agents or insulin. - Helps reduce fasting and post‑prandial blood glucose levels. - May be considered for patients who benefit from once‑daily dosing.

Glucophage XR may cause a range of side effects, most of which are mild and transient. Serious adverse reactions are less common but require medical attention.

Common: - Gastrointestinal upset such as nausea, diarrhea, or abdominal discomfort. - Metallic taste in the mouth. - Decreased appetite. - Mild headache. - Weight loss.

Serious: - Lactic acidosis, a rare but life‑threatening condition. - Severe skin reactions (e.g., Stevens‑Johnson syndrome). - Persistent vomiting or dehydration. - Significant elevation of liver enzymes. - Hypoglycemia when combined with other glucose‑lowering drugs.

Before starting Glucophage XR, certain health considerations should be reviewed to minimize risks.

- Assess renal function; avoid use in severe renal impairment. - Monitor liver enzymes; discontinue if significant hepatic disease is present. - Evaluate for conditions that predispose to hypoxia (e.g., heart failure, recent myocardial infarction). - Use caution in elderly patients due to increased risk of lactic acidosis. - Discontinue before any radiographic studies that use iodinated contrast agents. - Counsel patients on recognizing symptoms of lactic acidosis and to seek immediate care if they occur.

Glucophage XR can interact with several medications, affecting its efficacy or safety profile.

Avoid: - Iodinated contrast media used in imaging studies; may precipitate renal dysfunction. - Cimetidine, as it can increase metformin plasma concentrations. - Certain diuretics that may impair renal function.

Use with caution: - Alcohol, which can increase the risk of lactic acidosis. - Other antidiabetic agents, especially sulfonylureas, due to heightened hypoglycemia risk. - Beta‑blockers, which may mask hypoglycemia symptoms. - Corticosteroids, as they can raise blood glucose levels. - ACE inhibitors or ARBs, requiring monitoring of renal function.